STOCK TITAN

Esquire Financial Holdings, Inc. (ESQ) director receives stock grant award

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Esquire Financial Holdings, Inc. disclosed that one of its directors acquired 753 shares of restricted common stock on December 10, 2025 at a stated price of $0 as a restricted stock award. After this transaction, the director beneficially owns 2,620 shares of common stock in direct ownership.

The 753 restricted shares are scheduled to vest 100% on December 10, 2026. The reported holdings also include additional restricted stock that will vest in three equal annual installments beginning on December 3, 2027.

Positive

  • None.

Negative

  • None.
Insider Nigam Rena
Role Director
Type Security Shares Price Value
Grant/Award Common Stock 753 $0.00 --
Holdings After Transaction: Common Stock — 2,620 shares (Direct)
Footnotes (1)
  1. Shares of restricted stock vest 100% on December 10, 2026. Includes shares of restricted stock which vest in three equal annual installments commencing on December 3, 2027.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Nigam Rena

(Last) (First) (Middle)
100 JERICHO QUADRANGLE
SUITE 100

(Street)
JERICHO NY 11753

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Esquire Financial Holdings, Inc. [ ESQ ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
12/10/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 12/10/2025 A 753(1) A $0 2,620(2) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Shares of restricted stock vest 100% on December 10, 2026.
2. Includes shares of restricted stock which vest in three equal annual installments commencing on December 3, 2027.
/s/ Eric S. Bader, pursuant to power of attorney 12/16/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Esquire Financial Holdings (ESQ) report?

A director of Esquire Financial Holdings, Inc. acquired 753 shares of restricted common stock on December 10, 2025 at a stated price of $0 as an equity award.

How many ESQ shares does the director own after this Form 4 transaction?

Following the reported transaction, the director beneficially owns 2,620 shares of Esquire Financial Holdings common stock in direct ownership.

What is the vesting schedule for the 753 restricted ESQ shares?

The 753 shares of restricted stock reported in this filing vest 100% on December 10, 2026, according to the explanation of responses.

Are additional restricted ESQ shares included in the director's reported holdings?

Yes. The reported holdings include additional restricted stock that vests in three equal annual installments commencing on December 3, 2027.

Is the ESQ share ownership reported as direct or indirect on this Form 4?

The Form 4 indicates that the 2,620 shares of Esquire Financial common stock are held with direct (D) ownership by the reporting person.